China's dominance of the pharmaceutical market presents Europe with huge problems. A plan from the EU Commission aims to reduce dependencies. However, new US tariffs would also be felt in Europe.
By Manuel Changming Liu
China is planning a gradual opening: Strategic sectors such as telecommunications, biotechnology and medical services are to become accessible to foreign investors.
By Emily Kossak
The high dependence of German industrial companies on the People's Republic of China is one of the lessons learned from the Covid pandemic. Companies like Philipp Kirsch, a producer of laboratory refrigerators, now want to spend more money on key components in its value chain and acquire them in Europe. The big question: Is the consumer also prepared to pay higher prices?
By Marcel Grzanna
